Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFER | P55789 | 2/20 | 0.59 |
| ▸ | MAOB | P27338 | 4/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GRK6 | P43250 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15952484 | 0.87 | ESR1 (0.40) | GFERTDP1TAAR1CYP1A2CYP2A6 | |
| SCHEMBL26185016 | 0.80 | GFER (0.52) | GFERMAOBMAOAALDH1A1CYP3A4 | |
| SCHEMBL16424873 | 0.79 | GFER (0.50) | GFERMAOBMAOAALDH1A1CYP3A4 | |
| SCHEMBL8953980 | 0.79 | GFER (0.50) | GFERMAOBMAOAALDH1A1CYP3A4 | |
| SCHEMBL8954118 | 0.79 | GFER (0.50) | GFERMAOBMAOAALDH1A1CYP3A4 | |
| SCHEMBL24602755 | 0.78 | CYP1A2 (0.52) | ALDH1A1TDP1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17722492 | 0.78 | LPL (0.46) | GFERALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL18326533 | 0.77 | IDO1 (0.45) | MAOBALDH1A1NPC1MAPTRAB9A | |
| SCHEMBL20004512 | 0.76 | TAAR1 (0.50) | NPC1RAB9ASMN1; SMN2TAAR1CYP2A6 | |
| SCHEMBL21925685 | 0.76 | CA2 (0.41) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116678868-A | Method for detecting acetamiprid in food by anti-matrix effect of SERS-aptamer sensing technology | 山东省农业科学院 | 2023-09-01 | — | — | CN | disclosed |
| US-8279435-B2 | Nanostructured metal-polyaniline composites and applications thereof | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2012-10-02 | — | — | US | disclosed |
| US-7786037-B2 | Silver, gold, platinum, palladium; porous asymmetric membrane; acidic dopant of hydrochloric acid, phosphoric acid, citric acid, madelic acid, trifluoroacetic acid, para-toluenesulfonic; metal salt has reduction potential greater than polyaniline; easily recovered, reused hydrogenation catalyst | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2010-08-31 | — | — | US | disclosed |
| US-20100060894-A1 | NANOSTRUCTURED METAL-POLYANILINE COMPOSITES AND APPLICATIONS THEREOF | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2010-03-11 | — | — | US | disclosed |
| US-20080171656-A1 | Nanostructured metal-polyaniline composites | ENERGY, U.S. DEPARTMENT OF | 2008-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100060894-A1 | NANOSTRUCTURED METAL-POLYANILINE COMPOSITES AND APPLICATIONS THEREOF | PARG, PARN, FHIT | GFER 1094/4885MAOB 235/4885MAOA 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.